Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27175
Title: Safe administration of obinutuzumab to rituximab-intolerant patients.
Austin Authors: Manos, Kate ;Grigg, Andrew P 
Affiliation: Clinical Haematology
Issue Date: 4-Aug-2021
Date: 2021-08-04
Publication information: Leukemia & Lymphoma 2021; 62(14): 3552-3554
URI: https://ahro.austin.org.au/austinjspui/handle/1/27175
DOI: 10.1080/10428194.2021.1961232
Journal: Leukemia & Lymphoma
PubMed URL: 34348074
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

26
checked on Jul 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.